SSR180711C
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SSR180711C, covering 2009-07-20 to 2009-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease [Phase 2]